Keywords: عوامل ضد ویروسی مستقیم مستقیم; Hepatitis B virus (HBV); Hepatitis C virus (HCV); Breast cancer; Chemotherapy; HBV/HCV reactivation; Toxicity; HCV; hepatitis C virus; CHC; chronic hepatitis C; HBV; hepatitis B virus; CHB; chronic hepatitis B; DAAs; direct-acting antiviral agents; ER; es
مقالات ISI عوامل ضد ویروسی مستقیم مستقیم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-acting antiviral agents; Protease inhibitors; Polymerase inhibitors; NS5A inhibitors;
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; PWID; PWUD; IDU; Injection drug users; Direct-acting antiviral agents
Prevalence of relevant NS5A resistance-associated substitutions to elbasvir in genotype 1a hepatitis C virus patients in Spain
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-acting antiviral agents; Genotype substitution; Hepatitis C virus / human immunodeficiency virus-coinfection; Elbasvir implementation; Prevalence; Antivirales de acción directa; Sustitución genotÃpica; Coinfección virus de la hepatitis C / viru
Frecuencia de sustituciones relevantes asociadas a resistencia en la región NS5A a elbasvir en el virus de la hepatitis C en pacientes con genotipo 1a en España
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Antivirales de acción directa; Sustitución genotÃpica; Coinfección virus de la hepatitis C / virus de la inmunodeficiencia humana; Implementación elbasvir; Prevalencia; Direct-acting antiviral agents; Genotype substitution; Hepatitis C virus / human
Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Hepatitis C virus; Direct-acting antiviral agents; MIP-1β; RANTES; Biomarker;
No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-acting Antiviral Agents; Sustained Virologic Response; Race; Effectiveness; AASLD; American Association for the Study of Liver Diseases; CI; confidence interval; HCV; hepatitis C virus; HIV; human immunodeficiency virus; ICD; International Classifi
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Delta liver stiffness; Direct-acting antiviral agents; HCV; Hepatocellular carcinoma;
HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland China
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-acting antivirals; Resistance associated substitutions; DAAs; direct-acting antiviral agents; NI; nucleoside/nucleotide inhibitor; PI; protease inhibitor; RAS; resistance-associated substitution; SVR; sustained virologic response; SVR12; sustained
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-acting antiviral agents; Advanced liver disease; Hepatitis C; Hepatocellular carcinoma; Risk factor;
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir
Keywords: عوامل ضد ویروسی مستقیم مستقیم; POLARIS-1 and POLARIS-4; Fatigue; Work Productivity; Health Utility; Vitality; CLDQ-HCV; Chronic Liver Disease Questionnaire-HCV Version; DAAs; direct-acting antiviral agents; FACIT-F; Functional Assessment of Chronic Illness Therapy-Fatigue; HCV; hepatit
Consenso Mexicano para el Tratamiento de la Hepatitis C
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; AAD; antivirales de acción directa; AASLD; Asociación Americana para el Estud
The Mexican consensus on the treatment of hepatitis C
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; AASLD; American Association for the Study of Liver Diseases; AFP; alpha-fetopro
New direct-acting antivirals for patients with chronic HCV infection: can we monitor treatment using an HCV core antigen assay?
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Automatized systems; Correlation; HCV core antigen; Hepatitis C virus; Direct-acting antiviral agents;
Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4+ T cells contributes to viral persistence in chronic hepatitis C
Keywords: عوامل ضد ویروسی مستقیم مستقیم; BTLA; B and T lymphocyte attenuator; CTLA-4; cytotoxic T-lymphocyte antigen 4; DAAs; direct-acting antiviral agents; ELISA; enzyme-linked immunosorbent assay; FBS; fetal bovine serum; Gal-9; Galectin-9; HBV; hepatitis B virus; HCV; hepatitis C virus; HCVc
Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?
Keywords: عوامل ضد ویروسی مستقیم مستقیم; ALT; alanine aminotransferase; CHC; chronic hepatitis C; CI; confidence interval; DAAs; direct-acting antiviral agents; DCV; daclatasvir; EASL; The European Association for the Study of the Liver; GT; Genotype; HCC; hepatocellular carcinoma; HCV; hepatiti
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Antiviral treatment; Cirrhosis; Direct-acting antiviral agents; Hepatitis C; RAV; Treatment failure;
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Routine Clinical Practice; Direct-Acting Antiviral Agents; Cirrhosis; Genotype 4; DAA; direct-acting antiviral agent; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; OMV; ombitasvir; PTV; paritaprevir; r; ritonavir; RBV; riba
Hepatitis B and C
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Hepatitis B; Hepatitis C; Sustained virologic response; Pegylated interferon; Direct-acting antiviral agents; Spontaneous viral clearance;
Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C
Keywords: عوامل ضد ویروسی مستقیم مستقیم; CHC; chronic hepatitis C; HCV; Hepatitis C virus; PEG-IFN; pegylated interferon alfa; RBV; ribavirin; DAAs; direct-acting antiviral agents; GT1; genotype 1; GT4; genotype 4; IQR; inter-quartile range; OR; odds ratio; HCV; IL28B; Liver stiffness; Fibrosis
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; HCV-EHMs; HCV-extrahepatic manifestations; IFN; interferon; CV; cryoglobulinemic vasculitis; AVT; antiviral therapy; Peg-IFN; pegylated interferon; RBV; ribavirin; DAAs; direct-acting antiviral agents; FDA; food and drug administra
Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Hepatitis C virus; Hematopoietic cell transplantation; Direct-acting antiviral agents
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV NS5A inhibitor; Elbasvir; MK-8742; Direct-acting antiviral agents; DAA; HCV infection treatment; Tetracyclic core;
Hepatitis C during pregnancy, vertical transmission and new treatment possibilities
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Hepatitis C virus; Pregnancy; Vertical transmission; Risk factors; Direct-acting antiviral agents; Virus de la hepatitis C; Gestación; Transmisión vertical; Factores de riesgo; Antivirales de acción directa;
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitors
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV NS5A inhibitor; Elbasvir; MK-8742; Direct-acting antiviral agents; HCV infection treatment; Indole based tetracyclic core;
Hepatitis C durante la gestación, transmisión vertical y nuevas posibilidades de tratamiento
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Virus de la hepatitis C; Gestación; Transmisión vertical; Factores de riesgo; Antivirales de acción directa; Hepatitis C virus; Pregnancy; Vertical transmission; Risk factors; Direct-acting antiviral agents;
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study
Keywords: عوامل ضد ویروسی مستقیم مستقیم; AE; adverse events; DAAs; direct-acting antiviral agents; DCV; daclatasvir; EOT; end of treatment; GFR; glomerular filtration rate; HCV; hepatitis C virus; HIV; human immunodeficiency virus; IMS; immunosuppressive; LLOQ; lower limit of quantification; LT;
Research ArticleHCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; DAAs; direct-acting antiviral agents; SVR; sustained virological response; HCV; Viral kinetics; Mathematical modeling; SVR; Duration of therapy;
Research ArticleEfficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; GT; genotype; TPV; telaprevir; PegIFN; pegylated interferon; RBV; ribavirin; SVR; sustained virologic response; DAA; direct-acting antiviral agents; OBV; ombitasvir; PTV; paritaprevir; r; ritonavir; DSV; dasabuvir; IL28B; interleuk
From current status to optimization of HCV treatment: Recommendations from an expert panel
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Antiviral therapy; Cirrhosis; Direct-acting antiviral agents; HCV; Hepatitis C; Liver transplantation; Resistance
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-Acting Antivirals; ION-1; ION-2; ION-3; DAAs; direct-acting antiviral agents; HCV; hepatitis C virus; LiPA; Line Probe Assay; NI; nucleotide inhibitor; PI; protease inhibitor; RAS; resistance-associated substitution; SVR; sustained virologic respon
Research ArticleSofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; PegIFNα; pegylated interferon; RBV; ribavirin; SVR; sustained virologic response; DAAs; direct-acting antiviral agents; APRI; aminotransferase:platelet ratio index; ULN; upper limit of normal; LLOQ; lower limit of quantitation; NI
Research ArticleSafety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; DAAs; direct-acting antiviral agents; PegIFNα; pegylated interferon alfa; AE; adverse event; SAE; serious adverse event; SVR; sustained virologic response; DRESS; drug reaction with eosinophilia and systemic symptoms; Hepatitis C;
Research ArticleTrends in mortality after diagnosis of hepatitis C virus infection: An international comparison and implications for monitoring the population impact of treatment
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; NSW; New South Wales; BC; British Columbia; SVR; sustained virological response; DAAs; direct-acting antiviral agents; HAART; highly active anti-retroviral therapy; HPS; Health Protection Scotland; NRS; National Records of Scotland
Research ArticleGrazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
Keywords: عوامل ضد ویروسی مستقیم مستقیم; DAA; Direct-acting antiviral agents; PR; Peginterferon alfa and ribavirin; RAV; Resistance-associated variants; SVR; Sustained virologic response; C-SALVAGE; HCV genotype-1; Grazoprevir; Elbasvir; Direct-acting antiviral agents;
Original ResearchFull Report: Clinical-LiverSofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Hepatitis C Virus; Liver Transplantation; HCV Recurrence; Direct-Acting Antiviral Agents; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; LLOQ; lower limit of quantification; MELD; model for end-stage liver disease; pTVR; post-transplantation virol
Discovery of HCV NS5B thumb site I inhibitors: Core-refining from benzimidazole to indole scaffold
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; RdRp; Thumb site I; Indole; Anti-viral; Heterocycle; HCV; hepatitis C virus; RdRp; RNA-depended-RNA-polymerase; WHO; World Health Organization; HCC; hepatocellular carcinoma; SOC; standard of care; PEG-IFN-α; pegalated α-interferon; RVB; Ribavi
Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Drug; DAA; Direct-Acting Antiviral Agents; Clinical Trial Result; BMI; body mass index; CI; confidence interval; EC50; 50% effective concentration; FDA; US Food and Drug Administration; FDC; fixed-dose combination; HCV; hepatitis C virus; LLOQ; lower limi
Journal of Hepatology Update: Hepatitis CAntiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis C
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; PegIFN; pegylated interferon; RBV; ribavirin; SVR; sustained virologic response; DAAs; direct-acting antiviral agents; SOF; sofosbuvir; SIM; simeprevir; FDA; United States Food and Drug Administration; EMA; European Medicines Agenc
Liver, Pancreas and Biliary TractImpact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: A modelling approach
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-acting antiviral agents; HCV epidemic; Liver graft allocation; Markov model; Multi-organ procurement;
ReviewTherapeutic vaccines against hepatitis C virus
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; SoC; standard-of-care; DAAs; direct-acting antiviral agents; NAb; neutralising antibody; UTRs; untranslated regions; SR-BI; scavenger receptor class B type I; OCLN; tight-junction proteins occludin; CLDN-1; claudin-1; LDL-R; low de
Research ArticleVirologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202)
Keywords: عوامل ضد ویروسی مستقیم مستقیم; HCV; hepatitis C virus; PegIFN; pegylated interferon; RBV; ribavirin; SVR; sustained virologic response; DAAs; direct-acting antiviral agents; PIs; protease inhibitors; BID; twice daily; QD; once daily; LLOQ; lower limit of quantification; RT-PCR; reverse
Original ResearchFull Report: Basic and Translational-LiverA Serine Palmitoyltransferase Inhibitor Blocks Hepatitis C Virus Replication in Human Hepatocytes
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-Acting Antiviral Agents; DAAs; HCV Lifecycle; Drug; cDNA; complementary DNA; DAA; direct-acting antiviral agent; HCV; hepatitis C virus; IC50; 50% inhibitory concentration; PCR; polymerase chain reaction; PEG-IFN; pegylated interferon alfa-2a; RBV;
Glucose abnormalities in hepatitis C virus infection
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Direct-acting antiviral agents; Hepatitis C virus; Insulin resistance; Pegylated interferon; Ribavirin
HCV NS5A Inhibitors in Development
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Hepatitis C; Direct-acting antiviral agents; Daclatasvir; Asunaprevir; GS-7977; Pegylated interferon; Ribavirin;
Hepatitis C Viral Kinetics
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Mathematical modeling; Viral kinetics; Direct-acting antiviral agents; Protease inhibitors; Hepatitis C virus;
The Importance of Rapid Viral Suppression in the Era of Directly Acting Antiviral Therapy for Hepatitis C Virus
Keywords: عوامل ضد ویروسی مستقیم مستقیم; Hepatitis C; Direct-acting antiviral agents; Boceprevir; Telaprevir; Rapid viral response; Extended rapid viral response;